Pages that link to "Q31867854"

The following pages link to Copernicus revisited: amyloid beta in Alzheimer's disease (Q31867854):

Displaying 50 items.

• ApoE-dependent plasticity in Alzheimer's disease. (Q30341746) (← links)
• The effects of cholesterol on learning and memory. (Q33976829) (← links)
• Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta (Q34009618) (← links)
• The biochemical aftermath of anti-amyloid immunotherapy (Q34221510) (← links)
• Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age. (Q34342742) (← links)
• Feasibility of β-sheet breaker peptide-H102 treatment for Alzheimer's disease based on β-amyloid hypothesis (Q34457296) (← links)
• Alois Alzheimer revisited: differences in origin of the disease carrying his name (Q34571929) (← links)
• Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? (Q34669518) (← links)
• Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention (Q34677568) (← links)
• Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach (Q34727547) (← links)
• The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease (Q34750643) (← links)
• Antioxidants as treatment for neurodegenerative disorders (Q34974866) (← links)
• Neuroplasticity in Alzheimer's disease (Q34976296) (← links)
• The amyloid hypothesis: let sleeping dogmas lie? (Q35019455) (← links)
• Prospects for antiapoptotic drug therapy of neurodegenerative diseases (Q35092261) (← links)
• Beta-amyloid and cholinergic neurons (Q35098524) (← links)
• Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy (Q35113288) (← links)
• The application of functional genomics to Alzheimer's disease (Q35207554) (← links)
• Design strategies for anti-amyloid agents. (Q35209288) (← links)
• Barriers to developing a valid rodent model of Alzheimer's disease: from behavioral analysis to etiological mechanisms (Q35898532) (← links)
• Does beta-amyloid plaque formation cause structural injury to neuronal processes? (Q36003859) (← links)
• Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme (Q36016766) (← links)
• Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats (Q36044202) (← links)
• Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (Q36135513) (← links)
• Oxidative imbalance in Alzheimer's disease (Q36161854) (← links)
• Oxidative stress and inflammation in brain aging: nutritional considerations (Q36269329) (← links)
• The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. (Q36275654) (← links)
• Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. (Q36600440) (← links)
• Alzheimer disease--no target for statin treatment. A mini review (Q36634036) (← links)
• Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers (Q36799584) (← links)
• Treating the lesions, not the disease (Q36800729) (← links)
• Fruit polyphenols and their effects on neuronal signaling and behavior in senescence (Q36802182) (← links)
• Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? (Q36817040) (← links)
• Iron: the Redox-active center of oxidative stress in Alzheimer disease (Q36824768) (← links)
• The role of novel chitin-like polysaccharides in Alzheimer disease (Q37059465) (← links)
• Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease (Q37174350) (← links)
• Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration? (Q37599399) (← links)
• Nutrition, brain aging, and neurodegeneration. (Q37614750) (← links)
• Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications (Q37773826) (← links)
• Revisiting the cholinergic hypothesis in the development of Alzheimer's disease (Q37851630) (← links)
• The role of iron as a mediator of oxidative stress in Alzheimer disease (Q37996961) (← links)
• The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. (Q38094984) (← links)
• The dark sides of amyloid in Alzheimer's disease pathogenesis (Q38184783) (← links)
• The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy (Q38352298) (← links)
• The human β-amyloid precursor protein: biomolecular and epigenetic aspects (Q38365416) (← links)
• Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome (Q40510522) (← links)
• Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain (Q42454348) (← links)
• Muscarinic receptor subtype determines vulnerability to oxidative stress in COS-7 cells (Q43857842) (← links)
• Aluminum accumulation and membrane fluidity alteration in synaptosomes isolated from rat brain cortex following aluminum ingestion: effect of cholesterol. (Q44158908) (← links)
• Alzheimer’s disease: ageing-related or age-related? New hypotheses from an old debate (Q44461865) (← links)